India  

‘Covid-19 cases may peak in June-July’: AIIMS director Dr Randeep Guleria

Video Credit: HT Digital Content - Duration: 02:27s - Published
‘Covid-19 cases may peak in June-July’: AIIMS director Dr Randeep Guleria

‘Covid-19 cases may peak in June-July’: AIIMS director Dr Randeep Guleria

The director of All India Institute of Medical Sciences (AIIMS) has warned that Covid-19 pandemic in the country may not have peaked yet.

“According to modeling data and the way our cases are increasing, it is likely that peak can come in June and July.

But there are many variables and with time only we will know how much they are effective and the effect of extending the lockdown,” said Dr Randeep Guleria, AIIMS Director, according to ANI.


You Might Like

Related news from verified sources

Coronavirus outbreak: COVID-19 is likely to peak in June-July, says AIIMS-Delhi Director

As per the modeling data and the way India's COVID-19 cases are increasing, it is likely that peak...
Mid-Day - Published Also reported by •IndiaTimes


Managing hotspots is key to ‘blunted peak’: AIIMS director

AIIMS director Dr Randeep Guleria said on Thursday that if the Covid-19 hotspots are managed...
IndiaTimes - Published

Delhi: Hospital in Burari to start functioning as Covid-19 care centre in next 2-3 days, says Satyendar Jain

A 400-bed hospital in northwest Delhi's Burari area will start functioning as a Covid-19 care centre...
IndiaTimes - Published


Related videos from verified sources

'Unlock 1': Shopping malls, religious places to reopen from June 08 [Video]

'Unlock 1': Shopping malls, religious places to reopen from June 08

The Ministry of Home Affairs, on May 30 issued new guidelines for phased re-opening of all activities outside containment zones for the next one month. However, lockdown to continue in Containment..

Credit: ANI     Duration: 02:35Published
Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug [Video]

Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug

Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of toxicity if Hydroxychloroquine (HCQ) used as part of treatment for severe..

Credit: ANI     Duration: 01:26Published
Stigma still attached to Covid-19, people fear getting tested: AIIMS director [Video]

Stigma still attached to Covid-19, people fear getting tested: AIIMS director

All India Institute of Medical Science (AIIMS) Director, Dr Randeep Guleria on Saturday emphasised the importance of timely detection of Covid-19 to improve the rate of mortality. Guleria said many..

Credit: HT Digital Content     Duration: 01:43Published